Lyratherapeutics.com

Lyra Therapeutics

WEBOur proprietary technology integrates a proven anti-inflammatory medication and advanced materials engineering to create a treatment solution for CRS. Lyra Therapeutics’ drug …

Actived: 9 days ago

URL: https://lyratherapeutics.com/

Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 …

WEB-- Data from ENLIGHTEN I Pivotal Phase 3 Trial of LYR-210 in Chronic Rhinosinusitis (CRS) Anticipated Q2 2024 --WATERTOWN, Mass., March 21, 2024 (GLOBE …

Category: Health Go Health

Improving the Quality of Life for CRS Patients

WEBThe potential effect of LYR-210 on the quality of life of CRS patients was also observed based on the 36-item short form health survey (SF-36v2), which was also part of the …

Category: Health Go Health

Lyra Therapeutics Announces First Patient Enrolled in Pivotal …

WEBCRS is a highly prevalent inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities and is the fifth most common condition …

Category: Health Go Health

Phase 1 clinical study to assess the safety of a novel drug …

WEBHealth, Melbourne, Australia; 4Department of Surgery, Monash University, Melbourne, Australia; 5Otolaryngology–Head and Neck Surgery, Specialists at Forte 2, …

Category: Health Go Health

Lyra Therapeutics Advances Phase 2 BEACON Clinical Trial of LYR …

WEB21-point (37%) mean improvement in SNOT-22 total score at six weeks during the uncontrolled Part 1 stage of the 24-week BEACON trial First patient dosed in the …

Category: Health Go Health

Lyra Therapeutics Reports Third Quarter 2023 Financial Results and

WEBThese statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause the Company's actual …

Category: Health Go Health

Lyra Therapeutics Announces Positive Topline Results for …

WEBBased on my experience in Lyra’s Phase 1 and Phase 2 studies for LYR-210, I believe a drug-releasing nasal implant that may offer up to six months treatment would represent …

Category: Health Go Health

Job Opportunities

WEBJob Opportunities - Lyra Therapeutics. We are looking for talented individuals to join the Lyra Therapeutics team in the following positions: Lyra Therapeutics is an equal …

Category: Health Go Health

News Releases Lyra Therapeutics, Inc.

WEBNews Releases. Year. 2024. May 21, 2024. Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital. PDF Version. May 06, 2024. Lyra Therapeutics Reports …

Category: Health Go Health

Lyra Therapeutics to Present at the BofA Securities 2021 Virtual …

WEBWATERTOWN, Mass.--(BUSINESS WIRE)--May 6, 2021-- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development …

Category: Health Go Health

Lyra Therapeutics to Present Data Supporting LYR-210 for the …

WEBThree poster presentations to be featured at the 66th Annual Meeting of the American Rhinologic Society. WATERTOWN, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Lyra …

Category: Health Go Health

Lyra Therapeutics Reports Third Quarter 2022 Financial Results and

WEBThese statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause the company's actual …

Category: Health Go Health

Lyra Therapeutics Reports Fourth Quarter and Full Year 2022 …

WEB-- ENLIGHTEN I Pivotal Phase 3 Trial of LYR-210 in Pre-Surgical Chronic Rhinosinusitis (CRS) on Track to Complete Enrollment in mid-2023 -- -- Data from BEACON Phase 2 …

Category: Health Go Health

Lyra Therapeutics Reports First Quarter 2024 Financial Results and

WEB-- Phase 3 Results from ENLIGHTEN 1 Trial of LYR-210 in Chronic Rhinosinusitis (CRS) Expected in May --WATERTOWN, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- Lyra …

Category: Health Go Health

Investor Relations

WEBLyra Therapeutics, Inc. is a clinical-stage biotechnology company developing long-acting, anti-inflammatory nasal inserts for the treatment of chronic rhinosinusitis (CRS). Lyra …

Category: Health Go Health

Investor FAQs Lyra Therapeutics, Inc.

WEBLyra Therapeutics was incorporated as a Delaware corporation on November 21, 2005 under the name WMR Biomedical, Inc. On July 16, 2018, the name was formally …

Category: Medical Go Health

Events & Presentations Lyra Therapeutics, Inc.

WEBThe Investor Relations website contains information about Lyra Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.

Category: Health Go Health

SEC Filings Lyra Therapeutics, Inc.

WEBView HTML: Mar 22, 2024: Annual report which provides a comprehensive overview of the company for the past year. 10-K

Category: Health Go Health

Top Categories

› Appendicitis

› Gout

› Women's Health

› Thyroid

› Sleep

› Skin

› Sexual Health

› Senior Health

› Oral Health

› Mental Health

› Men's Health

› Medications

› Lung Conditions

› Infectious Disease

Popular Searched

› Age health disparities example

› Is haven healthcare a scam

› Vegetable oil health problems

› Health safety environment test

› Healthy foods in tokyo

› Ppc healthcare alison sheffield

› Information about mental health

› Carepoint home health prior lake

› Lgbtq mental health risks

› Manchester ky behavioral health

Recently Searched

› Senior whole health contact number

› Texas health license lookup

› Alluvion health family nurse practitioner

› Public health reporting arkansas

› Mercy home health log in

› Centre health medical barrack heights

› Health first orthopedic physicians

› Collective health member log in

› White miniature schnauzers health problems

› Monash health falls risk assessment

The medical information found on the MedUSafe website is designed to support, not to replace the relationship between patient and physician and the medical advice they may provide.